Kevin Leech feels it is appropriate timing for him to step down
A recent reseach note is responsible for the recent share price movement
Accura Announce The Appointment Of Alan Reade As Non
Chairman presents Interim Results
Notice Of Entry Into Facility Agreement And Allotment Of 500,000 Ordinary Shares.
Update on the Demerger and Change of Name
Update on the Demerger and Change of Name
Final results for the 12 months of business operations
Special resolution approved
Accura Pharma plc announces proposed Demerger and admission to trading on PLUS
Offer will remain open for acceptance until further notice
The Offer is today declared wholly unconditional in all respects
Download your Form of Acceptance and Authority and Offer Circular Details
Recommended Offer to Acquire PLUS-quoted Tridelta PLC (“Tridelta” or “the Company”).
Alan Reade Joins Accura As Chairman Of Its Advisory Board
Accura Pharma To Focus On The Gbp 9 Billion Animal Health Market